Table 3.
Non-ROs (%) | ROs (%) | Patients (N) | |
---|---|---|---|
2018 | 142 (80.23) | 35 (19.77) | 375 |
2019 | 199 (86.90) | 30 (13.10) | 371 |
2020 | 179 (74.27) | 62 (25.73) | 337 |
2021 | 174 (79.45) | 45 (20.55) | 309 |
2022 | 165 (77.10) | 49 (22.90) | 287 |
Non-ROs (%) | ROs (%) | Patients (N) | |
---|---|---|---|
2018 | 142 (80.23) | 35 (19.77) | 375 |
2019 | 199 (86.90) | 30 (13.10) | 371 |
2020 | 179 (74.27) | 62 (25.73) | 337 |
2021 | 174 (79.45) | 45 (20.55) | 309 |
2022 | 165 (77.10) | 49 (22.90) | 287 |